ArticlePloS one2026
GL-Net: A knowledge-guided Gaussian-gated and layered refinement network for 3D MRI segmentation of brain gliomas.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glioblastoma is a highly malignant brain tumor, and accurate lesion segmentation in MRI is essential for diagnosis, treatment planning, and prognosis assessment. This paper proposes a knowledge-guided 3D hybrid Transformer-CNN framework, GL-Net, which integrates prior knowledge through a Gaussian Gating Module (GGM) and a Layered Refinement Module (LRM), together with a novel Edge-Region Voxel Dynamic Weighted Loss Function. These modules collaboratively enhance feature activation, refine label-specific structures, and improve edge delineation, enabling robust segmentation even under limited-sample conditions. The proposed GL-Net was evaluated on the BraTS2019 and BraTS2021 datasets, achieving average Dice Similarity Coefficients (DSC) of 0.877 and 0.913, and Hausdorff Distances (HD) of 1.83 and 1.55, respectively-demonstrating highly competitive performance and a substantial reduction in boundary errors relative to the reported benchmarks of current data-driven approaches. Furthermore, to assess its clinical applicability, VASARI (Visually Accessible Rembrandt Images) feature extraction was performed using both the GL-Net-generated segmentation masks and the ground truth labels on the BraTS2019 dataset for glioblastoma (GBM) diagnosis. The diagnostic performances were nearly identical (GT AUC: 0.954 / GL-Net AUC: 0.949), and the DeLong test (p = 0.99) indicated no statistically significant difference between the two. These results suggest that GL-Net not only achieves highly competitive segmentation accuracy but also produces radiomic features comparable to expert manual annotations, providing complementary evidence of its potential clinical relevance. The proposed framework shows strong clinical potential for precise and consistent glioma delineation, providing valuable support for surgical planning, radiotherapy targeting, and diagnostic decision-making in clinical workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.